Introduction The Role of the Kidneys Drugs used in Renal Disease Drugs and Dialysis Renal Pharmacy Team
|
|
- Willa Britney Barton
- 5 years ago
- Views:
Transcription
1
2 Introduction The Role of the Kidneys Drugs used in Renal Disease Drugs and Dialysis Renal Pharmacy Team
3 Drugs play a major role in both treating and causing renal disease Doses of some drugs need to be changed in renal disease Clearance of drugs is different again in dialysis Renal pharmacists can help with doses and drug choice
4 Controls the water and electrolyte content of the body By filtration, secretion and reabsorption Keeps vital substances (e.g. protein) in the body Maintains the acid-base balance Excretes waste products, toxins and drugs Endocrine functions Activates Vitamin D Produces hormones (e.g. Erythropoeitin)
5 Acute Kidney Injury (AKI) Can be caused by drugs, sepsis, trauma Chronic Kidney Disease (CKD) Staged according to renal function Causes Inherited disease (e.g. polycystic kidneys) Acquired disease (e.g. nephrotic syndrome) Hypertension Diabetes
6 Treatment can be for the underlying disease e.g. cyclophosphamide to treat vasculitis Most drugs are aimed at treating the complications of renal disease EPO for renal anaemia Phosphate binders for renal bone disease ACE-I for protein loss in nephrotic syndrome Renal patients often have multiple comorbidities, so we need to consider their other treatments too
7 In renal failure, drugs are handled differently by the body Reduced absorption Increased permeability of the blood brain barrier Reduced protein binding Reduced metabolism Reduced clearance of drugs Doses of some drugs need to be altered in renal failure
8 Is the drug nephrotoxic? Avoid where possible e.g. Ciprofloxacin instead of Gentamicin Less of an issue if anuric Is the drug excreted unchanged in the urine? Ideally <25% Risk of accumulation Lower dose needed for same effect
9 How are metabolites excreted? Very little significant metabolism by the kidney Active metabolites may accumulate in ESRF E.g. Morphine-6-glucuronide Is there significant non-renal toxicity? If wide therapeutic window, e.g. Penicillins, dose adjustment may not be necessary Caution with LMWHs as CKD patients already at higher bleeding risk
10 The degree that the dose needs to be adjusted is according to an estimation of the patient s renal function Resources Renal Drug Handbook BNF Manufacturer s information Renal Pharmacist
11 MDRD Equation Reported on the VitalData/ CWS Not validated for drug dosing BSA = 1.73m 2 Cockcroft and Gault Equation Used for drug dosing Esp when narrow therapeutic index CrCl = (140 Age) x Weight(kg) x g Serum Creatinine g... Men = 1.23 Women = 1.04
12 Is the drug removed by dialysis? If not it doesn t matter when you give it If it is, give after if it is a ONCE daily drug This information is in the Renal Drug Handbook Peritoneal dialysis does not remove drugs, Dose as in ESRF
13 The extent to which drugs are removed by haemodialysis depends on Size of the drug (MW<500) Protein binding In plasma or tissue? High water solubility Low volume of distribution If the drug is only removed by HD, it should be only be given after dialysis e.g. Vancomycin (see ward protocol)
14 Dose 1 HD day or non-hd day Vancomycin 1g (patient <70kg) Vancomycin 1.5g (patient kg) Vancomycin 2g (patient >100kg) Dose 2 With next HD session And plan to give vancomycin with every subsequent haemodialysis session Dose 3 With next HD session Dose 4 With next HD session Vancomycin 750mg (patient <70kg) Vancomycin 1g (patient kg) Vancomycin 1.5g (patients >100kg) Check vancomycin level prior to next HD session Do not wait for levels before giving vancomycin Dose 3 Vancomycin 750mg (patient <70kg) Vancomycin 1g (patient kg) Vancomycin 1.5g (patients >100kg) Prescribe Dose 4, 5 and 6 according to vancomycin levels (mg/l) taken prior to Dose 3 Aim to maintain vancomycin levels of 15-20mg/L Vancomycin administration: 500mg or 750mg infuse in 100ml sodium chloride 0.9% during last 60 minutes of HD 1g infuse in 250ml sodium chloride 0.9% during last 90 mins 1.5g infuse in 250ml sodium chloride 0.9% during last 120 mins 2g infuse in 250ml sodium chloride 0.9% during last 150 mins < 5 Vanc 1.5g (1g if <70kg) Seek advice for subsequent antibiotic plan 5 to 9 Vanc 1.5g (1g if <70kg) 10 to 14 Vanc 1g 15 to 20 Vanc 750mg 21 to 25 Vanc 500mg > 25 Hold dose Dose 5 and Dose 6 With next two HD sessions Repeats of Dose 4 (except when vancomycin level >25mg/L prior to Dose 3) Vanc 1.5g (1g if <70kg) Vanc 1g Vanc 750mg Vanc 500mg Check vancomycin level prior to Dose 6 (take level before starting the HD session) Do not wait for levels before giving vancomycin Dose 6 Vanc 500mg Dose 7 With next HD session Prescribe Dose 7, 8 and 9 according to vancomycin levels (mg/l) taken prior to Dose 6 (see above) Aim to maintain vancomycin levels of 15-20mg/L Dose 8 and beyond Continue to prescribe vancomycin according to this guidance Check vancomycin levels prior to every 3 rd HD session (generally once weekly)
15 Uraemia Toxins can displace drugs from binding sites Leads to increased free drug levels Proteinuria Low plasma albumin levels an issue with drugs which are highly protein bound Leads to increased free drug levels Poor urine concentrating ability Nitrofurantoin relies on this, therefore ineffective when egfr <45ml/min
16 Tubular dysfunction Avoid thiazide diuretics when egfr <30ml/min Fluid restriction Consider volume of IV drugs Sodium content (e.g. Disp paracetamol) Drugs requiring constant fluid status (e.g. Li) Oedema Gut oedema can reduce GI drug absorption
17 Erythropoeitin deficiency Occurs early in CKD Replace with synthetic ESA Need to ensure adequate iron stores prior to starting Eprex First line ESA for haemodialysis patients Short acting, 1-3x/week dosing Start at units two-three times a week Mircera First line ESA for pre-dialysis, RTx and PD Long acting; monthly dosing Start around 50-75mcg (depending on wt)
18 Iron deficiency NICE 2015 put more emphasis on iron status Ferritin and TSATs Unit HD patients get Venofer on HD Others get TDI (Ferinject or Monofer) Vitamin B 12 deficiency Folate deficiency
19
20 Phosphate Binders No point taking them if not with food! First line... Calcium containing binders Calcichew, Calcium acetate If Calcium high, concerns re calcification... Alucaps, Lanthanum, Sevelamer Vitamin D analogues Alfacalcidol, calcitriol Colecalciferol??? Hyperparathyroidism Parathyroidectomy Cinacalcet
21 Calcification of blood vessels and soft tissue Treatment Pain relief Stop warfarin As much dialysis as possible Sodium thiosulphate 50ml of 50% solution (25g) after HD
22 Tinzaparin first line across N&T Doses according to time on HD initially Adjusted to clinical signs (e.g streaking, bleeding) Check with satellite unit on admission Some patients on heparin/ fondaparinux If on treatment dose Clexane, don t need extra anticoagulation on HD First line line lock = Citralock All should be prescribed on drug chart
23 AVF is best access option Better pump speeds Less risk of infection Blocked lines Algorithm... Check for mechanical issues Urokinase Protocol 3 push locks and 1 infusion = senior review Line sepsis Vancomycin for empirical treatment Blood cultures guide further treatment
24 Antibiotic stickers MicroGuide Includes N&T guidance and dosing Restricted antibiotics vuhb/adult Sepsis bundle
25 Guidance on MicroGuide Empirical treatment IP Vancomycin in one bag every 5-7 days PO Ciprofloxacin Further Abx guided by PD fluid/ blood cultures Should be prescribed on main drug chart as well as on PD chart Disconnection/ contamination of line
26 Types of donors Live donor Donors after Brain Death (DBD) Donors after Cardiac Death (DCD) Anti-rejection drugs Reduce risk of acute rejection i.e immune system attacking new kidney Doses must not be missed
27 Tacrolimus Prescribed by brand Adoport, Prograf, Advagraf, Envarsus Doses 12 hours apart (empty stomach) Pre-dose level Lots of drug-drug interactions Mycophenolate mofetil Doses 12 hours apart GI side effects (may switch to Myfortic) Increased risk of cancer SPF 50
28 Prednisolone Best taken in morning with breakfast Gradual reduction (unless short course) Often given omeprazole for gastroprotection Ciclosporin Only used in transplants from ages ago Similar issues to Tacrolimus Azathioprine Likewise, unless once daily preferable or pregnancy (in place of MMF) Sirolimus Used in place of tacrolimus to avoid nephrotoxicity Also needs pre-dose levels
29 Increased risk of infection if taking immunosuppression Pneumocystis jirovecii (PJP AKA PCP) Co-trimoxazole for 6 months 480mg daily (960mg MWF if cyclophosphamide) Cytomegalovirus (CMV) Valganciclovir for 3 months Dose depends on renal function Other prophylaxis given if patient at risk Donor history Hep B/C history in donor or recipient Either from area where TB endemic
30 Ward based roles Medicines reconciliation for all new patients Daily review of all charts Technician led non-stock top up TTHs at ward level Don t send down to pharmacy, bleep us Transplant clinic Prescription and supply of all anti-rejection drugs for all transplant patients Annual review, medication counselling, queries re drug choice
31 Home therapies Iron prescribing, nocturnal HD medication review Renal medication queries Via ward, HD units, Drs, nurses, other pharmacists, patients Directorate level roles Expenditure reporting Service development
32 Used for medicines management Drs now do electronic TTHs Signed off by pharmacist on WCP Ward view to see which TTHs have been seen by pharmacy team Can t tell you whether they have been dispensed though! Can also access old TTHs, GP record
33 Rob Bradley Bleep 5707 Helen Thomas Bleep 6351 Hayley Jones Bleep 6360 Jenna Walker Bleep 6359 Gareth Bryant Bleep???? Edwina Jenkins Bleep 6523 Clinic pharmacy Ext 41222
34
Medicines for anaemia and mineral bone disease
Patient Information: Medicines NHS Logo here Medicines for anaemia and mineral bone disease Health & care information you can trust The Information Standard Certified Member Working together for better
More informationIrish Practice Nurses Association Annual Conference Tullamore Court Hotel OCTOBER 6 th 2012
Irish Practice Nurses Association Annual Conference Tullamore Court Hotel OCTOBER 6 th 2012 Susan McKenna Renal Clinical Nurse Specialist Cavan General Hospital Renal patient population ACUTE RENAL FAILURE
More informationWhat is this leaflet about?
Patient Information: Medicines Medicines commonly taken by people after a transplant or with an autoimmune disease Health & care information you can trust The Information Standard Certified Member Working
More informationCommon Medication for People Receiving Haemodialysis
Common Medication for People Receiving Haemodialysis Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm
More informationCKD: Bone Mineral Metabolism. Peter Birks, Nephrology Fellow
CKD: Bone Mineral Metabolism Peter Birks, Nephrology Fellow CKD - KDIGO Definition and Classification of CKD CKD: abnormalities of kidney structure/function for > 3 months with health implications 1 marker
More informationClinical guidance for the management of. Cytomegalovirus (CMV) in. kidney/pancreas transplant patients. Guidance prepared by Cardiff and Vale UHB
Clinical guidance for the management of Cytomegalovirus (CMV) in kidney/pancreas transplant patients Guidance prepared by Cardiff and Vale UHB Kidney/Pancreas Transplant Virus MDT Sarah Browne (Consultant
More informationChronic Kidney Disease
Chronic Kidney Disease Presence of kidney damage or decreased kidney function for three or more months, - necessary to distinguish CKD from acute kidney disease. Ascertained either by kidney biopsy or
More informationAfter a kidney transplant
The nursing staff will make sure that you are comfortable and will monitor the transplanted kidney to make sure it is working well. When you wake up you will notice that you will have a number of different
More informationegfr 34 ml/min egfr 130 ml/min Am J Kidney Dis 2002;39(suppl 1):S17-S31
Update on Renal Therapeutics Caroline Ashley Lead Pharmacist Renal Services UCL Centre for Nephrology, Royal Free Hospital, London Kongress für Arzneimittelinformation January 2011 What are we going to
More informationBACKGROUND Measuring renal function :
A GUIDE TO USE OF COMMON PALLIATIVE CARE DRUGS IN RENAL IMPAIRMENT These guidelines bring together information and recommendations from the Palliative Care formulary (PCF5 ) BACKGROUND Measuring renal
More informationTrust Guideline for the Use of Parenteral Vancomycin and Teicoplanin in Adults
A clinical guideline recommended for use: In: By: For: Division responsible for document: Key words: Names of document authors: Job titles of document authors: Name of document author s Line Manager: Job
More informationClinical Guidelines for Use of Antibiotics. VANCOMYCIN (Adult)
VANCOMYCIN (Adult) Please always prescribe VANCOMYCIN in the Variable Dose Antibiotic section of the EPMA SUPPLEMENTARY drug chart (and add a placeholder on the electronic drug chart). 1 Background Vancomycin
More informationClinical Guideline Bone chemistry management in adult renal patients on dialysis
Clinical Guideline Bone chemistry management in adult renal patients on dialysis This guidance covers how to: Maintain serum phosphate 0.8 to 1.7mmol/L 1 Maintain serum corrected calcium 2.1 to 2.5mmol/L
More informationINTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS
Title of guideline (must include the word Guideline (not protocol, policy, procedure etc) INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS Author: Contact Name and Job Title
More informationCardiff & Vale (C&V) UHB Corporate Medicines Management Group (c MMG) SHARED CARE. Drug: AZATHIOPRINE Protocol number: CV 04
Cardiff & Vale (C&V) UHB Corporate Medicines Management Group (c MMG) SHARED CARE Drug: AZATHIOPRINE Protocol number: CV 04 Indication: RENAL, PANCREAS OR COMBINED RENAL PANCREAS TRANSPLANTATION LIVER
More informationEFFECTIVE SHARE CARE AGREEMENT
Specialist details Patient identifier Name: Tel: EFFECTIVE SHARE CARE AGREEMENT For the specialist use of Erythropoietin Stimulating Agent (ESA) Therapy (formerly known as EPO) for the correction of Anaemia
More informationAnalgesia in patients with impaired renal function Formulary Guidance
Analgesia in patients with impaired renal function Formulary Guidance Approved by Trust D&TC: January 2010 Revised March 2017 Contents Paragraph Page 1 Aim 4 2 Introduction 4 3 Assessment of renal function
More informationFull title of guideline INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS. control
Full title of guideline Author: Contact Name and Job Title Division and specialty Scope Explicit definition of patient group to which it applies (e.g. inclusion and exclusion criteria, diagnosis) Changes
More informationChronic Kidney Disease (CKD) and egfr: Decision and Dilemma. Dr Bhavna K Pandya Consultant Nephrologist University Hospital Aintree
Chronic Kidney Disease (CKD) and egfr: Decision and Dilemma Dr Bhavna K Pandya Consultant Nephrologist University Hospital Aintree Topics CKD background egfr background Patient with egfr Referral Guidelines
More informationDrug Dosing in Renal Insufficiency. Coralie Therese D. Dimacali, MD College of Medicine University of the Philippines Manila
Drug Dosing in Renal Insufficiency Coralie Therese D. Dimacali, MD College of Medicine University of the Philippines Manila Declaration of Conflict of Interest For today s lecture on Drug Dosing in Renal
More informationKidney damage with normal or increased GFR Kidney damage with mild reduction in GFR
CHRONIC KIDNEY DISEASE Contents Stages of Chronic Kidney Disease Dosing adjustments Hyperphosphataemia management Secondary hyperparathyroidism Anaemias Hyperkalaemia Acidosis Hypertension STAGES OF CHRONIC
More informationCOMMON MEDICINES USED IN CKD CHRONIC KIDNEY DISEASE
CHRONIC KIDNEY DISEASE 1 This information is intended to help you understand why you need to take your medicines. There are multiple medicines that are used to control the symptoms related to CKD. You
More informationRenal Disease and PK/PD. Anjay Rastogi MD PhD Division of Nephrology
Renal Disease and PK/PD Anjay Rastogi MD PhD Division of Nephrology Drugs and Kidneys Kidney is one of the major organ of drug elimination from the human body Renal disease and dialysis alters the pharmacokinetics
More informationChronic Kidney Disease in Primary Care
Clinical Stream Chronic Kidney Disease in Primary Care Dr Gerald Waters Dr Gerald Waters Renal Physician Chronic Kidney Disease Chronic Kidney Disease Normal functions of Kidneys Management of CKD Drugs
More informationDialysis: the long case
Dialysis: the long case Prof Mark Brown St George Public Hospital, Kogarah The case SD 1. What significant things have been omitted from the history? 2. Physical findings 70 RTA; mitral regurg murmur;
More informationGUIDELINES FOR ADMINISTRATION OF INTRAVENOUS IRON IN ADULTS WITH CHRONIC KIDNEY DISEASE
GUIDELINES FOR ADMINISTRATION OF INTRAVENOUS IRON IN ADULTS WITH CHRONIC KIDNEY DISEASE Full Title of Guideline: Author (include email and role): Division & Speciality: Scope (Target audience, state if
More informationCardiff & Vale (C&V) UHB Corporate Medicines Management Group (c MMG) SHARED CARE. Drug: TACROLIMUS Protocol number: CV 43
Cardiff & Vale (C&V) UHB Corporate Medicines Management Group (c MMG) SHARED CARE Drug: TACROLIMUS Protocol number: CV 43 Indications: RENAL, PANCREAS OR COMBINED RENAL PANCREAS TRANSPLANTATION IN ADULTS.
More informationDisclosures. Topics. Staging and GFR. K-DOQI Staging of Chronic Kidney Disease. Definition of Chronic Kidney Disease. Chronic Kidney Disease
Disclosures Chronic Kidney Disease Consultant: Baxter Healthcare J. Kevin Tucker, M.D. Brigham and Women s Hospital Massachusetts General Hospital Topics Staging of chronic kidney disease (CKD) How to
More informationNOTTINGHAMSHIRE AREA PRESCRIBING COMMITTEE SHARED CARE PROTOCOL AGREEMENT
NOTTINGHAMSHIRE AREA PRESCRIBING COMMITTEE SHARED CARE PROTOCOL AGREEMENT Phosphate Binders for the Treatment of Hyperphosphataemia in adults with Chronic Kidney Disease OBJECTIVES To outline referral
More informationMycophenolate Mofetil (MMF)
SCG: For Transplant patients The following guidelines are designed to provide information relating to mycophenolate mofetil and to outline the responsibilities of the primary and secondary care teams in
More informationChronic Kidney Disease (CKD) Stages. CHRONIC KIDNEY DISEASE Treatment Options. Incident counts & adjusted rates, by primary diagnosis Figure 2.
Chronic Kidney Disease (CKD) Stages Stage 1 GFR > 90 (evidence of renal disease) Stage 2 GFR 60-89 Stage 3 GFR 30-59 Stage 4 GFR 15-29 Stage 5 GFR
More informationStRs and CT doctors in haematology. September Folinic acid dose modified.
High dose Methotrexate and folinic acid rescue Full Title of Guideline: Author (include email and role): Division & Speciality: Clinical Guideline Review Date September 2018 GUIDELINE FOR THE USE OF HIGH
More informationCardiff & Vale (C&V) UHB Corporate Medicines Management Group (c MMG) SHARED CARE. Drug: CICLOSPORIN Protocol number: CV 06
Cardiff & Vale (C&V) UHB Corporate Medicines Management Group (c MMG) SHARED CARE Drug: CICLOSPORIN Protocol number: CV 06 Indication: RENAL, PANCREAS OR COMBINED RENAL PANCREAS TRANSPLANTATION IN ADULTS
More informationUse ideal body weight (IBW) unless actual body weight is less. Use the following equation to calculate IBW:
Amikacin is a partially restricted (amber) antibiotic for the treatment of infections due to gentamicin resistant Gram negative bacilli or as advised by microbiology. As with other aminoglycosides, therapeutic
More informationKent Kidney Care Centre: Medicines prescribed for people with chronic kidney disease
Kent Kidney Care Centre: Medicines prescribed for people with chronic kidney disease Information for patients The following pages offer you information on some of the medicines that you may need. It is
More informationIV Vancomycin dosing and monitoring Antibiotic Guidelines. Contents. Intro
IV Vancomycin dosing and Antibiotic Guidelines Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): as above Authors Division: DCSS & Tertiary Medicine Unique
More informationAcute Kidney Injury shared guidance
Acute Kidney Injury shared guidance Acute Kidney Injury (AKI) Fluid balance assessment (NICE CG 169) Assess the patient s likely fluid and electrolyte needs 1.History previous limited intake, thirst, abnormal
More informationSecondary Hyperparathyroidism: Where are we now?
Secondary Hyperparathyroidism: Where are we now? Dylan M. Barth, Pharm.D. PGY-1 Pharmacy Resident Mayo Clinic 2017 MFMER slide-1 Objectives Identify risk factors for the development of complications caused
More informationProfessor Suetonia Palmer
Professor Suetonia Palmer Department of Medicine Nephrologist Christchurch Hospital Christchurch 14:00-14:55 WS #108: The Kidney Test - When To Test and When to Refer ( and When Not To) 15:05-16:00 WS
More informationNHS Grampian Staff Guidance for the Administration of Intravenous Vancomycin in Adults via Intermittent (pulsed) Infusion
Acute Sector NHS Grampian Staff Guidance for the Administration of Intravenous Vancomycin in Adults via Intermittent (pulsed) Infusion Co-ordinators: Gillian Macartney Fiona McDonald Specialist Antibiotic
More informationCardiff & Vale (C&V) UHB Corporate Medicines Management Group (c MMG) SHARED CARE. Drug: MYCOPHENOLATE MOFETIL/SODIUM Protocol number: CV 15
Cardiff & Vale (C&V) UHB Corporate Medicines Management Group (c MMG) SHARED CARE Drug: MYCOPHENOLATE MOFETIL/SODIUM Protocol number: CV 15 Indication: RENAL, PANCREAS OR COMBINED RENAL PANCREAS TRANSPLANTATION
More informationPRESCRIBING IN LIVER AND RENAL DISEASE
THERAPEUTICS FOR INDEPENDENT PRESCRIBERS PRESCRIBING IN LIVER AND RENAL DISEASE Number 6 in a series of 15 articles on Therapeutics Aims and Objectives To outline the pathophysiological changes that occur
More informationWEEK. MPharm Programme. Acute Kidney Injury. Alan M. Green MPHM13: Acute Kidney Injury. Slide 1 of 47
MPharm Programme Acute Kidney Injury Alan M. Green 2017 Slide 1 of 47 Overview Renal Function What is it? Why does it matter? What causes it? Who is at risk? What can we (Pharmacists) do? How do you recognise
More informationHEALTHYSTART TRAINING MANUAL. Living well with Kidney Disease
HEALTHYSTART TRAINING MANUAL Living well with Kidney Disease KIDNEY DISEASE CAN AFFECT ANYONE! 1 HEALTHYSTART PROGRAMME HEALTHYSTART is a lifestyle management programme to assist you to remain healthy
More informationHYDROCHLORIDE FOR THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS WITH END-STAGE RENAL DISEASE ON MAINTENANCE DIALYSIS THERAPY
UK RENAL PHARMACY GROUP SUBMISSION TO THE NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE on CINACALCET HYDROCHLORIDE FOR THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS WITH END-STAGE RENAL DISEASE
More information5/10/2014. Observation, control of blood pressure. Observation, control of blood pressure and risk factors.
Overview The Kidneys Nicola Barlow Clinical Biochemistry Department City Hospital Renal physiology Renal pathophysiology Acute kidney injury Chronic kidney disease Assessing renal function GFR Proteinuria
More informationCa, Phos and Vitamin D Metabolism in Pre-Dialysis Patients
Ca, Phos and Vitamin D Metabolism in Pre-Dialysis Patients A. WADGYMAR, MD Credit Valley Hospital, Mississauga, Ontario, Canada. June 1, 2007 1 Case: 22 y/o referred to Renal Clinic Case: A.M. 29 y/o Man
More informationTacrolimus. Information for Parents/Carers
Tacrolimus Information for Parents/Carers St Michael s C Ward 01 878 4258 01 878 4431 Main Hospital Number 01 878 4200 What is tacrolimus and what is it used for? Tacrolimus is an immunosuppressant drug,
More informationOxford Kidney Unit What do my blood and dialysis results mean? Information for patients
Oxford Kidney Unit What do my blood and dialysis results mean? Information for patients page 2 If you are on haemodialysis (HD) or peritoneal dialysis (PD) this leaflet is for you. It will provide you
More informationMedicines Formulary Blood and electrolyte disorders, and vitamin deficiencies
Medicines Formulary Blood and electrolyte disorders, and vitamin deficiencies Contents: Blood disorders 1 1. Anaemia 2 A. Non-renal patients 2 B. Patients with chronic kidney disease under the care of
More informationGuideline for the Management of Continuous IV Vancomycin Infusion in Neonates on NICU A Clinical Guideline recommended for use
Guideline for the Management of Continuous IV Vancomycin Infusion in A Clinical Guideline recommended for use For Use in: By: For: Division responsible for document: Key words: Name and job title of document
More informationContents. Authors Name: Christopher Wong: Consultant Nephrologist Anne Waddington: Renal Pharmacist Eimear Fegan : Renal Dietitian
Cheshire and Merseyside Renal Units Guidelines on the Management of Chronic Kidney Disease - Mineral Bone Disorder (adapted from Greater Manchester) Authors Name: Christopher Wong: Consultant Nephrologist
More informationCHRONIC KIDNEY DISEASE (CKD)
CHRONIC KIDNEY DISEASE (CKD) CKD implies longstanding (more than 3 months), and usually progressive, impairment in renal function. In many instances, no effective means are available to reverse the primary
More informationQUICK REFERENCE FOR HEALTHCARE PROVIDERS
KEY MESSAGES 1 SCREENING CRITERIA Screen: Patients with DM and/or hypertension at least yearly. Consider screening patients with: Age >65 years old Family history of stage 5 CKD or hereditary kidney disease
More informationUnderstanding Your Medications
PD Education Booklet 8 Understanding Your Medications What you will learn: Why your medications are important Medications your kidney doctor may prescribe, and what they do Medications that may be added
More informationGreater Manchester Guidelines on the Management of Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD)
Greater Manchester Guidelines on the Management of (CKD-MBD) Classification: Clinical Guideline Lead Author: Smeeta Sinha, Consultant Nephrologist Additional author(s): Elizabeth Lamerton, Renal Pharmacist
More informationRenal Excretion of Drugs
Renal Excretion of Drugs 3 1 Objectives : 1 Identify main and minor routes of Excretion including renal elimination and biliary excretion 2 Describe its consequences on duration of drugs. For better understanding:
More informationPaediatric Prescribing Pocket Guide September 2014 (Version 1)
PAGE 1 Paediatric Prescribing Pocket Guide September 2014 (Version 1) In children, the risk of medication errors is often exacerbated by the need for calculations to determine the dose. Prescribing errors
More informationMycophenolate. Information for Parents/Carers
Mycophenolate Information for Parents/Carers St Michael s C Ward 01 878 4258 01 878 4431 Main Hospital Number 01 878 4200 What is mycophenolate and what is it used for? Mycophenolate is an immunosuppressant
More informationTrust Guideline. for Ciclosporin Treatment & Monitoring for Adult* Patients with Acute, Severe Ulcerative Colitis. (*ie aged 16 years and over)
Trust Guideline for Ciclosporin Treatment & Monitoring for Adult* Patients with Acute, Severe Ulcerative Colitis (*ie aged 16 years and over) abc A guideline recommended for use In: Gastroenterology/Medical
More informationFiltration and Reabsorption Amount Filter/d
Renal Physiology 2011 Lisa M. Harrison-Bernard, PhD Contact me at lharris@lsuhsc.edu Renal Physiology Lecture 3 Renal Clearance and Glomerular Filtration Filtration and Reabsorption Amount Filter/d Amount
More informationChronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Dietetic Management Protocol
Nutrition and Dietetic Service Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Dietetic Management Protocol Authors Hilary Mathieson, Renal Dietitian Paul McKeveney, Consultant Nephrologist
More informationTacrolimus (Adoport, Prograf, Modigraf or Advagraf )
Shared Care Guideline DRUG: Tacrolimus (Adoport, Prograf, Modigraf or Advagraf ) for Renal Transplant (Adults) Introduction: Indication: Prophylaxis of transplant rejection in kidney recipients Tacrolimus
More informationOffice Management of Reduced GFR Practical advice for the management of CKD
Office Management of Reduced GFR Practical advice for the management of CKD CKD Online Education CME for Primary Care April 27, 2016 Monica Beaulieu, MD FRCPC MHA CHAIR PROVINCIAL KIDNEY CARE COMMITTEE
More informationPersistent post transplant hyperparathyroidism. Shiva Seyrafian IUMS-97/10/18-8/1/2019
Persistent post transplant hyperparathyroidism Shiva Seyrafian IUMS-97/10/18-8/1/2019 normal weight =18-160 mg In HPT= 500-1000 mg 2 Epidemiology Mild 2 nd hyperparathyroidism (HPT) resolve after renal
More informationPPP 1. Continuation, modification, and discontinuation of a medication
PRESCRIBING POLICIES: 4.7 PHARMACIST AUTHORITY The College of Pharmacists of BC Professional Practice Policy (PPP) 58 Medication Management (Adapting a Prescription) became effective April 1, 2009. The
More informationThe Renal System. David Carroll
The Renal System David Carroll dcarroll06@qub.ac.uk https://www.davidontheinter.net Learning Objectives What you need to pass your exam Anatomy Physiology Pharmacology Pathophysiology Renal Anatomy Renal
More informationMedical Emergencies in Dialysis Patients
Medical Emergencies in Dialysis Patients John Anderton Consultant Renal Physician Lancashire Teaching Hospitals NHS Foundation Trust Talk Plan A Flavour of Dialysis patients Emergencies in HD patients
More informationRicky Bell Renal/ICM Registrar
Ricky Bell Renal/ICM Registrar Objectives When to call renal How to manage the patient with AKI How the manage the patient with CKD (HD/PD) Special AKI situations What do the guidelines say? My referral
More informationTRANSPLANTATION SERIES
TRANSPLANTATION SERIES What are the Complications of Transplantation Key points: Possible problems after a transplant Risks of immunosuppression General side effects of taking immunosuppressant drugs What
More informationChronic Kidney Disease
Chronic Kidney Disease Chronic Kidney Disease (CKD) Guideline (2010) Chronic Kidney Disease CKD: Executive Summary of Recommendations (2010) Executive Summary of Recommendations Below are the major recommendations
More informationSouthern Trust Anticoagulant Team
CLINICAL GUIDELINES ID TAG Title: Author: Speciality / Division: Directorate: Anticoagulation- Primary Care Guidance for reviewing patients on DOACs Southern Trust Anticoagulant Team Haematology Acute
More informationTACROLIMUS (PROGRAF, Modigraf Adoport, Adagraf ) Prescribing Guidelines for Adult Liver Transplant Patients and autoimmune liver disease
Oxford Gastroenterology Unit Shared Care Protocol & Information for GPs TACROLIMUS (PROGRAF, Modigraf Adoport, Adagraf ) Prescribing Guidelines for Adult Liver Transplant Patients and autoimmune liver
More informationPrescribing Framework for Mycophenolate Mofetil or Mycophenolic Acid (Myfortic ) Post Solid Organ Transplant
Hull & East Riding Prescribing Committee Prescribing Framework for Mycophenolate Mofetil or Mycophenolic Acid (Myfortic ) Post Solid Organ Transplant Patient s Name:.. NHS Number: Patient s Address:...
More informationEveryday Vasculitis (or what questions do we get asked most!) Lucy Smyth Renal Consultant
Everyday Vasculitis (or what questions do we get asked most!) Lucy Smyth Renal Consultant What is it? Why have I got it? How can we treat it? Why do I feel like I do? What do the blood tests mean? Will
More informationTDM. Measurement techniques used to determine cyclosporine level include:
TDM Lecture 15: Cyclosporine. Cyclosporine is a cyclic polypeptide medication with immunosuppressant effect. It has the ability to block the production of interleukin-2 and other cytokines by T-lymphocytes.
More informationGemcitabine, Carboplatin and Bevacizumab (gynae)
Gemcitabine, Carboplatin and Bevacizumab (gynae) Indication Second line advanced epithelial ovarian, fallopian tube or primary peritoneal cancer. WHO performance status 0 or 1. (Funding via the CDF) ICD-10
More informationEssential Shared Care Agreement: Lithium
Ref No. E042 Essential Shared Care Agreement: Lithium Please complete the following details: Patient s name, address, date of birth Treatment (indication, dose regimen, brand name) Monitoring (proposed
More informationDefinitions. You & Your New Transplant ` 38
Definitions Acute Short, relatively severe Analgesic Pain medicine Anemia A low number of red blood cells Anesthetic Medication that dulls sensation in order to reduce pain Acute Tubular Necrosis (ATN)
More informationGUIDELINES FOR BLOOD GROUP / ABO INCOMPATIBLE RENAL TRANSPLANTATION
GUIDELINES FOR BLOOD GROUP / ABO INCOMPATIBLE RENAL TRANSPLANTATION Author: Contact Name and Job Title Dr Gavin McHaffie (Consultant Nephrologist) Ext 55932 Dr Alastair Ferraro (Consultant Nephrologist)
More informationTHE KIDNEY AND SLE LUPUS NEPHRITIS
THE KIDNEY AND SLE LUPUS NEPHRITIS JACK WATERMAN DO FACOI 2013 NEPHROLOGY SIR RICHARD BRIGHT TERMINOLOGY RENAL INSUFFICIENCY CKD (CHRONIC KIDNEY DISEASE) ESRD (ENDSTAGE RENAL DISEASE) GLOMERULONEPHRITIS
More informationNHS Lothian- University Hospitals Division
Pre-transplant ograph or Consultant Surgeon: Transplant Nurse: Consultant Diabetologist: Diabetes Specialist Nurse: Dietitian: NHS Lothian- University Hospitals Division Consultant Radiologist: Recipient
More informationHaemodialysis Blood Results
Haemodialysis Blood Results Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient information leaflets.htm Introduction
More informationIntervention Study 2016 West ISD. Gillian Ritchie Clinical Pharmacist
Intervention Study 2016 West ISD Gillian Ritchie Clinical Pharmacist Introduction Annual data collection Two weeks All Medicines Management Team interventions Details recorded Classified by type Outcomes
More informationChronic Kidney Disease Mineral Bone Disease
NHS Logo here Chronic Kidney Disease Mineral Bone Disease (CKD-MBD) Patient Information Health & care information you can trust The Information Standard Certified Member Working together for better patient
More informationThe Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009
The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009 Teresa Northcutt, RN BSN Primaris Program Manager, Prevention - CKD MO-09-01-CKD This material was prepared by Primaris,
More informationAcute Kidney Injury (AKI) Undergraduate nurse education
Acute Kidney Injury (AKI) Undergraduate nurse education Year One Developed Summer 2017 Overview Basic A & P of: Urinary system Kidneys Followed by: Introduction to Acute Kidney Injury Urinary System The
More informationManaging Fluid, Diet and Medications
Managing Fluid, Diet and Medications This lesson covers: Fluid and body weight Managing your diet Understanding your medications It is important that you feel comfortable with the information and procedures
More information8/22/1395 Dr. F. Moeinzadeh
1 How I treat CKD Dr. Firouzeh Moeinzadeh Táá áàtçà ÑÜÉyxááÉÜ Éy axñ{üéäézç \áyt{tç hç äxüá àç Éy `xw vtä fv xçvxá 2 Aim of this lesson How I diagnosis a CKD patient? How I follow a CKD patient? How I
More informationEdoxaban Switch Programme - Frequently Asked Questions
Edoxaban Switch Programme - Frequently Asked Questions What should I tell patients? NHS Tayside is reviewing all patients currently receiving a Direct Oral Anticoagulant (DOAC) for stroke prevention in
More informationHaving a pancreas transplant alone (PTA)
Having a pancreas transplant alone (PTA) This leaflet explains more about having a pancreas transplant alone (PTA), including the benefits, risks, alternatives, and what you can expect at the time of the
More informationPICU CARD SURG Post Operative Cardiac Transplant Age LESS than 6 months (Page 1 of 5)
(Page 1 of 5) Code Status Full code Status/Admit/Transfer/Discharge Surgical Procedure(s) and date performed (if applicable): Cardiologist: Cardiac Surgeon: Intensivist: Patient Care CMV status Donor CMV
More informationDrug Name: Lithium Clinical Indications: Treatment and prophylaxis of mania; bipolar disorder; augmentation therapy in treatment resistant depression
SHARED CARE PROTOCOL AND INFORMATION FOR GPS Drug Name: Lithium Clinical Indications: Treatment and prophylaxis of mania; bipolar disorder; augmentation therapy in treatment resistant depression Version:
More informationAntibody incompatible kidney transplantation from a deceased donor
Antibody incompatible kidney transplantation from a deceased donor This leaflet explains more about antibody incompatible renal transplantation from a deceased donor. It will tell you why you were offered
More informationInformation for patients with kidney disease attending the Low Clearance Clinic
Information for patients with kidney disease attending the Low Clearance Clinic Why am I attending this Clinic? Your kidneys are not working effectively. This means they cannot do their usual jobs such
More informationPancreas Transplantation. Sonia Clarke-Swaby Recipient Kidney/pancreas Transplant Co-ordinator Guy s Hospital
Pancreas Transplantation Sonia Clarke-Swaby Recipient Kidney/pancreas Transplant Co-ordinator Guy s Hospital Introduction Selection criteria, New innovation Complications, Success rates, Life expectancy
More informationChronic Kidney Disease The 6 Pillars. Dr. Tiina Podymow Associate Professor Division of Nephrology McGill University Health Centre
Chronic Kidney Disease The 6 Pillars Dr. Tiina Podymow Associate Professor Division of Nephrology McGill University Health Centre None Disclosures Objectives 1. Describe evidence-based measures to slow
More informationCKD-MBD CKD mineral bone disorder
CKD Renal bone disease Dr Mike Stone University Hospital Llandough Affects 5 10 % of population Increasingly common Ageing, diabetes, undetected hypertension Associated with: Cardiovascular disease Premature
More informationPaediatric Renal Disease
Pharmacy Department Paediatric Renal Disease Andrew.wignell@nuh.nhs.uk NUH Pharmacy At the end of the session you should be able to: Determine the level/type of renal dysfunction in a child and what the
More information